Autoantibodies in lupus erythematosus
Mark Goodfield
Lupus erythematosus (LE) is an autoimmune or connective-tissue disease, in which vascular, cutaneous, joint and systemic disease coexist, to a greater or lesser degree, in all patients. One of the hallmarks of LE, in addition to rheumatoid arthritis, systemic sclerosis, dermatomyositis and Sjögren’s syndrome, is the production of a variety of non-organ-specific autoantibodies.
Dermatology in practice 2002; 10(3): 10–13
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Group Ltd and, together with the content, is bound by copyright. Copyright © 2018 Hayward Group Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)